Vivos Therapeutics is a medical research and development company focused on breathing wellness.
Vivos Therapeutics has raised $2.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Vivos Therapeutics's investors include Alliance Global Partners, Seneca Partners, Streeterville Capital.
Vivos Therapeutics is headquartered in Littleton, United States.
Vivos Therapeutics is a medical research and development company focused on breathing wellness.
Vivos Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vivos Therapeutics — Funding & Investors." VCBacked, April 7, 2026, https://www.vcbacked.co/company/vivos-therapeutics. Accessed November 16, 2026.
VCBacked. (2026). Vivos Therapeutics — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/vivos-therapeutics
{{cite web |title=Vivos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vivos-therapeutics |website=VCBacked |access-date=November 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Vivos Therapeutics? Request a listing update